EsoCap finalises recruitment for eosinophilic esophagitis study
Candidate ESO-101 will treat participating patients across five European countries
Read More
Tag: eosinophilic
GSK’s Nucala approved for younger asthma patients
GlaxoSmithKline’s Nucala has been approved for use in paediatric patients with severe eosinophilic asthma.
Read More
GSK’s asthma biologic hits quality of life goal
GlaxoSmithKline has presented new data showing that its asthma drug Nucala “significantly improves” quality of life and lung function in patients with a severe, eosinophilic form of the condition.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
